中文  English
Home
All Sessions
CNAF '18
Nov 15-16, 2018
CNAF '17
Nov 09-10, 2017
CNAF '16
Nov 09-10, 2016
CNAF '15
Nov 18-19, 2015
CNAF '14
Nov 05-07, 2014
CNAF '13
Sep 11-13, 2013

Event Description


Nucleic acids science plays a key role in precision medicine, genetic therapy and new solutions for human health. Continuous discovery of new RNA function, drug targets and biomarks, bioinformatics and emergence of innovative nucleic acids technologies are driving forces for the field and hold enormous promise for the future scientific and technological progress. The China Nucleic Acids Forum (CNAF) led by Nobel Prize winners is an international forum at the forefront of these developments, aims to push forward communications and collaborations in and abroad, and has been successfully held five times since 2013. The CNAF has attracted high-profile speakers, including Nobel Prize winners, to highlight recent advances in nucleic-acid based medicine, scientific discoveries, diagnostics and industrial trends. It has been widely recognized as the premier forum in Asia for advancing nucleic acids research and drug development. The 2018 CNAF will feature 20+ globally prominent experts discussing the latest advances in nucleic acids research and development.


● Latest Advances in Genetic and Nucleic acids-based Therapeutics       
 Latest Discoveries in Non-coding RNA Research, Structure & Functions and Bioinformatics     
● Latest Progress in Nucleic acids-based Clinical Trials       
 Latest Applications in Nucleic acids Biomarkers and Diagnostics      




Torsten HOFFMANN, PhD

Chief Operating Officer
Silence Therapeutics, Germany



Muthiah MANOHARAN, PhD

Senior Vice President, Drug Discovery
Alnylam Pharmaceuticals, USA Board Director
Oligonucleotide Therapeutics Society







Ekkehard LEBERER, PhD

Professor, Senior Director, Sanofi, Germany
Founding Director, COMPACT Consortium



Craig MELLO, PhD

Professor, University of Massachusetts
Howard Hughes Medical Institute, USA
Nobel Prize in Physiology or Medicine (2006)







Dong-ki LEE, Ph. D.

Professor of Chemistry, Sungkyunkwan University,
Korea Founder and CEO, OliX Pharmaceuticals, Korea



Laura SEPP-LORENZINO, PhD

Vice President, Head of Nucleic Acid Therapies,
Vertex Pharmaceuticals, USA







Wei LI, PhD

Professor of Bioinformatics
Dan L. Duncan Cancer Center
Department of Molecular and Cellular Biology
Baylor College of Medicine, USA



Mikiko C. SIOMI, PhD

Professor, Department of Biological Sciences
Graduate School of Science
The University of Tokyo, Japan







Zhen LI, PhD

Senior Vice President
Chemistry and Manufacturing at Arrowhead
Pharmaceuticals, USA



Bruce SULLENGER, PhD

Professor, Duke University Medical Center